Roche and Harvard enlist Chinese technology park for cancer therapeutic development

On October 24, biotechnology-focused Suzhou Biobay (see the August 30, 2011 LRCHJ) inked a research collaboration agreement with Roche and Harvard University to develop new treatments for cancer and other diseases. The alliance will see Roche and Biobay shoulder equal funding responsibility to suppo...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Japan's METI announces financial support for overseas CCS projects

News Commentary | February 25, 2021

Since Japan announced its carbon neutrality pledge, the Ministry of Economy, Trade and Industry (METI) has launched a product database for CO2‑derived products and will now provide financial support for overseas carbon capture and sequestration (CCS) projects. The focus on non‑Japan CCS projects ... Not part of subscription

Dubai's economic agency launches new digital health-focused incubator and accelerator

News Commentary | April 30, 2021

The new incubator and accelerator, called Ztartup, aims to further the role of Dubai as a knowledge center and innovation hub in the region. The Middle East, most notably Saudi Arabia, the United Arab Emirates, and Qatar, has overseen major investments from the government in building R&D ... Not part of subscription

BioNTech to set up its regional headquarters and an mRNA vaccine manufacturing facility in Singapore

News Commentary | May 12, 2021

Pfizer's biotech partner that developed the mRNA vaccine against COVID‑19 has moved quickly to ensure it can be elastic in its response to shifting regional and global supply needs for its vaccine given the unpredictable outbreaks in recent times. This move also comes just weeks after Sanofi ... To read more, click here.